Large Global MNC players prefers CRAMS facility based out of Europe for their research work for any of their molecules starting from phase zero to phase three. Carbogen Amcis contributes 5055% of total revenue and 5-10% growth rate expected from this Share holding pattern as on Sep 2016 (%)...